TP53 and pulmonary fibrosis: CXCL10 and CXCL11 are known to attenuate bleomycin-induced pulmonary fibrosis CXCL10 and CXCL11 were increased by 25- and >10-fold, respectively, reflecting an antifibrotic activity of Ad-p53.